The Beauty Industry Compliance Certificate

A regulatory claim travels down a chain: from the product development team that formulates and selects the claim, to the marketer who writes the brief, to the creator who publishes the content, to the consumer who acts on it.

What BICC Is

BICC is a structured certificate program covering the federal and platform rules that govern beauty marketing — from FDA cosmetic and drug classification to FTC endorsement disclosure, MoCRA registration, and the brand-brief process that determines whether content stays inside or outside what a product can legally claim. Every participant completes a shared regulatory core, then a role track matched to their seat in the chain: the Creator track, for evaluating and responding to brand briefs, or the Brand track, for marketing and product development teams — covering how claims get selected and substantiated upstream, and how briefs get written so they never ask a creator to make a claim the product can't support.

Who BICC Is For

Brand founders, marketing leads, PD teams, and compliance teams. The Brand track certifies your own team: how briefs get written, where claims must route through regulatory or legal review, and how documentation and approval workflows hold up when an FDA inquiry, FTC investigation, or class action discovery request lands. Certifying your creators and your teams is what reasonable care looks like in practice. Claims risk doesn't start at the brief — it starts at formulation and claim selection, which is why the Brand track is built for product development teams as much as marketers.

Beauty content creators. A verifiable credential that signals to brands you understand the rules, and a practical framework you carry into every piece of content going forward.

Influencer agencies and roster managers. A way to credential your creator roster at scale, differentiate your representation, and reduce contract risk across your portfolio.

What BICC Covers

• FDA cosmetic and drug classification — what makes a product a cosmetic, when language pushes a product into drug territory, and why the line matters

• FTC endorsement and disclosure rules — material connections, the 2023 Endorsement Guides, what "clear and conspicuous" actually requires, and where most creator content fails

• MoCRA registration and ingredient safety — what changed, what brands and creators now need to know, and how it shows up in compliant content

• Beauty enforcement history and current sweeps — real warning letters, real consent orders, real settlements, and the patterns that produce them

• Social platform policy — where Instagram, TikTok, and YouTube rules diverge from federal law, and how to navigate both

• Creator track — reading and responding to brand briefs, and applied practice: decoding what a brief actually authorizes, recognizing where improvisation creates risk, pushing back constructively, and a content self-assessment framework.

• Brand track — writing compliant briefs, and documentation & governance: commissioning content that stays inside what the product can legally claim, routing claims to regulatory and legal review rather than authoring them, and the recordkeeping and approval workflows that demonstrate reasonable care.

How the Credential Works

BICC is independently developed and reviewed by subject-matter experts in beauty regulatory affairs and cosmetic chemistry. Participants enroll by role, complete the shared core plus their track and an applied assessment, and earn a verifiable credential — listable on LinkedIn, in media kits, in agency rosters, and in brand vendor-selection documentation. The credential is the practical artifact. The deeper output is a working framework for evaluating any beauty claim — in a brief or in a post — against the rules that actually apply.

About

The Beauty Industry Compliance Certificate (BICC) is a Pretty Equity program.

Pretty Equity is the advisory and publishing platform led by Melory Johnson, 25-year beauty industry leader with experience across product development, regulatory compliance, manufacturing, and commercialization, with more than a decade of medical and regulatory writing alongside it.